Chunxiao Liu Selected Research

Luciferins

3/2017	Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.
8/2015	A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model.
1/2015	Efficacy of intravesical Bacillus Calmette-Guérin therapy against tumor immune escape in an orthotopic model of bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunxiao Liu Research Topics

Disease

71	Neoplasms (Cancer) 02/2024 - 05/2012
25	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 10/2012
16	Urinary Bladder Neoplasms (Bladder Cancer) 09/2023 - 08/2011
12	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2019
12	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2012
11	Carcinogenesis 01/2022 - 08/2014
10	Breast Neoplasms (Breast Cancer) 10/2022 - 09/2017
8	Inflammation (Inflammations) 02/2024 - 08/2017
8	Carcinoma (Carcinomatosis) 01/2023 - 06/2012
8	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 08/2015
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 02/2012
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019 - 12/2010
4	Hemorrhage 04/2023 - 10/2013
4	Poisoning 11/2022 - 11/2015
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 12/2015
3	Osteoporosis 03/2024 - 12/2020
3	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 09/2016
3	Alzheimer Disease (Alzheimer's Disease) 06/2020 - 01/2018
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2015
3	Hyperplasia 01/2019 - 01/2018
3	Urinary Calculi (Urinary Calculus) 01/2016 - 11/2013
2	Colitis 03/2024 - 01/2019
2	Experimental Arthritis 01/2023 - 01/2019
2	Pain (Aches) 01/2023 - 01/2023
2	Gouty Arthritis 01/2023 - 04/2021
2	Infections 01/2023 - 01/2016
2	Rhabdomyosarcoma 11/2022 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 01/2019
2	Gout 01/2022 - 01/2020
2	Circulating Neoplastic Cells 12/2021 - 07/2014
2	Liver Neoplasms (Liver Cancer) 03/2021 - 01/2019
2	Myocarditis (Carditis) 10/2020 - 01/2019
2	Body Weight (Weight, Body) 10/2020 - 09/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2019 - 03/2013

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 02/2024 - 05/2012
11	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2016
7	Long Noncoding RNAIBA 01/2023 - 01/2016
7	Messenger RNA (mRNA)IBA 10/2022 - 05/2012
7	Sirolimus (Rapamycin)FDA Link 01/2019 - 03/2015
6	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 01/2015
5	CytokinesIBA 02/2024 - 10/2015
5	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2015
5	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 12/2013
4	AndrogensIBA 01/2024 - 10/2012
4	Phosphotransferases (Kinase)IBA 01/2023 - 01/2017
4	LigandsIBA 01/2022 - 07/2014
4	B-Cell Activating FactorIBA 01/2019 - 12/2015
4	CadmiumIBA 01/2019 - 08/2015
3	Dextran SulfateIBA 03/2024 - 01/2019
3	Ribonucleases (Ribonuclease)IBA 02/2024 - 01/2021
3	NucleotidesIBA 09/2023 - 04/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 12/2017
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022 - 01/2018
3	Peptides (Polypeptides)IBA 08/2021 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2013
3	nitroxolineIBA 01/2021 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
3	B7-H1 AntigenIBA 01/2021 - 01/2017
3	Caspase 3 (Caspase-3)IBA 10/2020 - 11/2015
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2016
3	Immunoglobulin G (IgG)IBA 01/2019 - 01/2013
3	Docetaxel (Taxotere)FDA Link 01/2018 - 10/2012
3	CateninsIBA 01/2018 - 01/2016
3	LuciferinsIBA 03/2017 - 01/2015
3	Small Interfering RNA (siRNA)IBA 11/2015 - 01/2013
2	nodakeninIBA 03/2024 - 12/2023
2	Hormones (Hormone)IBA 01/2024 - 01/2017
2	CalciumIBA 11/2023 - 12/2020
2	LipidsIBA 11/2023 - 09/2020
2	Folic Acid (Vitamin M)FDA LinkGeneric 09/2023 - 07/2014
2	Capsules (Microcapsules)IBA 04/2023 - 03/2021
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 09/2020
2	Vitamin D FDA LinkGeneric 01/2023 - 12/2020
2	Therapeutic UsesIBA 01/2023 - 06/2020
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2023 - 01/2020
2	Janus KinasesIBA 01/2023 - 01/2020
2	ResveratrolIBA 11/2022 - 11/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2022 - 01/2020
2	Alkaline PhosphataseIBA 03/2021 - 10/2020
2	CollagenIBA 10/2020 - 01/2019
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 01/2017
2	Serine Proteases (Serine Protease)IBA 01/2020 - 01/2020
2	ThioamidesIBA 01/2020 - 01/2020
2	EnzymesIBA 01/2020 - 01/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 08/2017

Therapy/Procedure

23	Therapeutics 04/2024 - 01/2013
7	Castration 01/2024 - 10/2014
6	Immunotherapy 02/2024 - 01/2020
5	Drug Therapy (Chemotherapy) 09/2023 - 01/2016
3	Cystectomy 11/2022 - 06/2012
3	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 02/2012
2	Ovariectomy (Oophorectomy) 03/2024 - 12/2023
2	Catheters 04/2023 - 10/2013
2	Stents 01/2023 - 03/2013
2	Cryosurgery 12/2021 - 11/2018
2	Percutaneous Nephrolithotomy 04/2020 - 11/2013
2	Local Anesthesia 04/2020 - 11/2013